PRO TECHnology To Showcase Kanguru’s Exceptional AES 256 Hardware Encrypted Devices and Duplicators at GISEC 2024
MILLIS, Mass.–(BUSINESS WIRE)–#Dubai—PRO TECHnology is excited to announce its participation with Kanguru in GISEC Global 2024, a premier cybersecurity... Read more.
PitchBook Launches Global VC Ecosystem Dashboard to Rank World’s Top Startup Cities
SEATTLE–(BUSINESS WIRE)–PitchBook, the premier data provider for the private and public equity markets today released The Global VC Ecosystem Dashboard... Read more.
The AGC Group Makes Donations to Help Victims of Eastern Taiwan Earthquake
TOKYO–(BUSINESS WIRE)–The AGC Group, which has offices in Taiwan such as AGC Display Glass Taiwan Inc. and AGC Electronics Taiwan Inc., announced that... Read more.
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
LJI and RevolKa will Research Nex-gen Vaccine Antigens by using AI-driven Protein Engineering Platform TOKYO–(BUSINESS WIRE)–RevolKa Ltd. (Norio Hamamatsu,... Read more.
UNITE HERE Local 11: Workers at Aimbridge-Operated SaMo Hotel Submit Letter to City Attorney, Calling for Investigation Into Hotels’ Compliance With Panic Button Law Following Allegations of Sexual Misconduct
Striking workers to speak at pension fund meeting with investments in Aimbridge SANTA MONICA, Calif.–(BUSINESS WIRE)–Dozens of workers at the Hampton... Read more.
Southwest Bancshares, Inc., Announces Texas Partners Bank as the Regional Bank Brand
With over $2 billion in assets, Texas Partners Bank celebrates 17 years of powering partnerships in Central Texas communities. SAN ANTONIO–(BUSINESS WIRE)–Southwest... Read more.
Two Top Rating Agencies Reaffirm Metropolitan’s Strong Credit Ratings
Prudent financial policies, comprehensive resource planning in district’s new biennial budget cited as foundation of ratings from S&P, Moody’s LOS ANGELES–(BUSINESS... Read more.
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative... Read more.
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative... Read more.
CORRECTING and REPLACING Anue Water Technologies Adds Four New Channel Partners to Serve Wastewater Treatment Customers in California, Nevada, Illinois, Michigan, Iowa, Nebraska, Ontario and the Maritime Provinces
ALPHARETTA, Ga.–(BUSINESS WIRE)–First channel partner in list should read: Rockwell Solutions for California and Nevada (instead of R.C. Beach for California... Read more.